TrialLeukemia & lymphoma2010

Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.

Tait Shanafelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.